Drugs / Insuplant
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01194882 Comparator | Nov 2010 → Feb 2018 | type 1 diabetes mellitus | Sanofi | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Insuplant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01194882 ↗ |
| Modality | Protein / enzyme biologic | “a semisynthetic insulin, the only one used so far.” PMID 24735100 ↗ Apr 2014 |
| Route | Other | “Route of administration: Intraperitoneal use” NCT01194882 ↗ |